Immix Biopharma, Inc. Share Price
NASDAQ: IMMX$0.00
+0.00 (0.00%) Immix Biopharma, Inc. Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
Immix Biopharma, Inc. Share Price Chart
$0.00$0.00
L
H
Immix Biopharma, Inc. Stock Fundamentals & Key Indicators
Market Cap N/A | PE Ratio (TTM) N/A | Dividend Yield N/A |
EPS (TTM) $-0.89 | Revenue (TTM) N/A | Return On Equity (TTM) -31.39% |
Profit Margin N/A | Debt to Equity 0.11 | Quarterly Earnings Growth YoY -72.68% |
Immix Biopharma, Inc. Quarterly Profit & Loss
All figures in USD
Immix Biopharma, Inc. Annual Profit & Loss
All figures in USD
About Immix Biopharma, Inc.
Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.
Immix Biopharma, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|
IMMX Share Price FAQs
What is Immix Biopharma, Inc. share price today?
Immix Biopharma, Inc. share price today is $0.00 as on August 9, 2026 at 9:16 am IST.
What is the 52 week high and 52 week low of Immix Biopharma, Inc. stock?
52 week high/low data for Immix Biopharma, Inc. is currently unavailable.
What is IMMX's net income for the last quarter?
IMMX's net income for the last quarter is -0.01B USD.
Can I buy IMMX shares in India?
Yes. You can buy IMMX in India by opening an international trading account.